https://www.medscape.com/viewarticle/993715
A new update to the American Diabetes Association's Standards of Care advises use of the fibrosis-4 (FIB-4) index for screening and use of GLP-1 agonists or pioglitazone for treatment.
Create an account or login to join the discussion